Item
ASCORBIC ACID USP FN GR KOSHER LUWEI (3020672 215 11M)
Preservative
Locations
Location name | Address |
---|---|
Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shuangfeng Industrial Park Zichuan District Zibo City, SD 255000 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Allergens.pdf | 2/28/2024 | 2/27/2026 |
Animal Testing Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Animal Testing Statement.pdf | 4/15/2024 | 4/15/2026 |
Lot Code | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | batch number statement.pdf | 5/10/2022 | 5/9/2025 |
BSE - TSE | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | BSE_TSE_.pdf | 5/12/2022 | 5/11/2025 |
GMO | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | C5997432025.pdf | 3/24/2025 | 12/22/2025 |
CoA Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | coa-3240113005.pdf | 3/8/2024 | 3/8/2026 |
Country of Origin | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | COUNTRY OF ORIGIN.pdf | 9/1/2022 | 8/31/2025 |
WADA/NSF/NFL Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Doping Free (WADA) Statement.pdf | 7/18/2023 | 7/17/2025 |
California Prop. 65 | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | e California Proposition 65 Statement.pdf | 4/15/2024 | 4/15/2026 |
EtO Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | ETO DECLARATION- VC.pdf | 4/15/2024 | 4/15/2026 |
HACCP Process Flow Diagram | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Flow Chart-VC.pdf | 4/15/2024 | 4/15/2026 |
FSVP Assessment Form | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | FSVP Assessment Form.pdf | 10/17/2024 | 10/17/2025 |
Gluten | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Gluten Free Statement.pdf | 4/15/2024 | 4/15/2026 |
GRAS/NDI/ODI Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | GRAS Compliance Confirmation.pdf | 1/23/2025 | 1/23/2028 |
HARPC Food Safety Plan (Item) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | HARPC Food Safety Plan Statements.pdf | 11/2/2023 | 11/1/2026 |
Heavy Metal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | heavy metal for VC.pdf | 4/27/2023 | 4/26/2025 |
Label Claims | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2026 |
Label Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2025 |
Label Guidance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2026 |
No Animal Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement.pdf | 7/17/2024 | 7/17/2025 |
Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement.pdf | 1/23/2025 | 1/23/2028 |
Irradiation Status Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | irradition.pdf | 2/16/2024 | 2/15/2026 |
Item Questionnaire | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Item Questionnaire.pdf | 1/23/2025 | 1/23/2028 |
Melamine | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Melamine Declaration.pdf | 7/17/2024 | 7/17/2025 |
HACCP | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | most recent version of plan of HACCPFrom Luwei.pdf | 2/19/2025 | 2/19/2028 |
Halal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | MUI-HALAL certificate 2022.pdf | 11/30/2022 | 11/29/2026 |
National Bioengineered Food Disclosure Standard (Simplified) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | National Bioengineered Food Disclosure Standard Simplified.pdf | 1/23/2025 | 1/23/2028 |
Natural | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Natural.Synthetic Statement Template.pdf | 7/17/2024 | 7/17/2025 |
Nutrition | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Nutrition.pdf | 3/13/2023 | 3/12/2026 |
Organic | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Organic use status statement for VC(From Luwei).pdf | 5/14/2023 | 5/13/2025 |
Kosher | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | OUV2-3B60CA6.pdf | 3/31/2024 | 3/31/2025 |
Food Contact Packaging Certificate of Compliance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | PACKING DECLARATION.pdf | 4/12/2023 | 4/11/2025 |
Pesticide | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Pesticides.pdf | 6/21/2023 | 6/20/2025 |
Phthalate Esters Letter | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Phthalate Esters.pdf | 7/17/2024 | 7/17/2025 |
Residual Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Residual Solvents Confirmation.pdf | 7/17/2024 | 7/17/2025 |
Safety Data Sheet (SDS) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SDS.pdf | 7/12/2023 | 7/11/2026 |
Sewage Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Sewage Statement.pdf | 4/15/2024 | 4/15/2026 |
Shelf Life | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shelf Life Statement Form.pdf | 1/23/2025 | 1/23/2028 |
Product Specification Sheet | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SPECIFICATION(revsied).pdf | 8/3/2022 | 8/2/2025 |
Suitability Requirements | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Suitability Requirements.pdf | 4/11/2023 | 4/10/2026 |
Vegan/Vegetarian Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | VEGAN CERTIFICATE.pdf | 3/29/2023 | 3/28/2025 |